纳福多肽
Search documents
啤酒跨界到纳豆,燕京啤酒为何进军大健康产业?公司这样说→
Cai Jing Wang· 2025-12-12 10:20
Core Insights - Yanjing Beer is expanding into the health industry with its Yanjing Nutrition initiative, focusing on promoting self-developed health products like natto and polypeptides [1][2] - As of the first half of 2025, beer products still account for 92.26% of Yanjing Beer's revenue, amounting to 7.896 billion yuan [1] - The company aims to strengthen its core beer business while diversifying into health products, indicating a strategic shift towards a broader market [1][3] Group 1: Health Product Development - Yanjing Natto, made from fermented soybeans, is highlighted for its high nutritional value, containing essential amino acids, calcium, iron, potassium, and vitamin K2 [2] - The company has established Beijing Yanjing Biotechnology Co., Ltd. in collaboration with the China Food Fermentation Industry Research Institute, focusing on a dual-driven model of "independent research and collaborative development" [2] - Yanjing Beer is committed to providing high-quality health products, emphasizing a focus on fermentation and health [2] Group 2: Financial Performance - For the first nine months of 2025, Yanjing Beer reported a revenue of 13.433 billion yuan, a year-on-year increase of 4.57%, and a net profit of 1.770 billion yuan, up 37.45% [4] - The company is implementing a diversified strategy, combining beer and beverage marketing to enhance its product matrix and market presence [4] Group 3: Product Diversification - Yanjing Beer has launched a beverage line, including the Best Soda series, which aims to complement its beer offerings and expand its commercial portfolio [4] - The health product range includes various items such as natto capsules, polypeptides, organic whole milk powder, probiotics, and fermented liquids, showcasing the company's commitment to health [5]
燕京啤酒:燕京营养家是布局大健康产业的重要举措,重点推广燕京纳豆、纳福多肽等产品
Cai Jing Wang· 2025-12-12 07:45
近日,燕京啤酒在互动平台向投资者表示,燕京营养家是燕京啤酒布局大健康产业的重要市场举措,由 北京燕京中发生物技术有限公司专业运营,作为其线下销售渠道,重点推广燕京纳豆、纳福多肽等自主 研发的健康产品。燕京啤酒总部位于北京市顺义区,公司股票于1997年7月在深交所挂牌上市交易。 2025年1至9月,燕京啤酒实现营收65.45亿元,同比增长8.58%(调整后);实现归母净利润14.66亿 元,同比下降4.28%(调整后)。2025年上半年,燕京啤酒的啤酒产品实现营收78.96亿元,占营收比重 为92.26%。 ...